ArticleComputational intelligence and neuroscience2022
A Decisive Metaheuristic Attribute Selector Enabled Combined Unsupervised-Supervised Model for Chronic Disease Risk Assessment.
Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advanced predictive analytics coupled with an effective attribute selection method plays a pivotal role in the precise assessment of chronic disorder risks in patients. Traditional attribute selection approaches suffer from premature convergence, high complexity, and computational cost. On the contrary, heuristic-based optimization to supervised methods minimizes the computational cost by eliminating outlier attributes. In this study, a novel buffer-enabled heuristic, a memory-based metaheuristic attribute selection (MMAS) model, is proposed, which performs a local neighborhood search for optimizing chronic disorders data. It is further filtered with unsupervised K-means clustering to remove outliers. The resultant data are input to the Naive Bayes classifier to determine chronic disease risks' presence. Heart disease, breast cancer, diabetes, and hepatitis are the datasets used in the research. Upon implementation of the model, a mean accuracy of 94.5% using MMAS was recorded and it dropped to 93.5% if clustering was not used. The average precision, recall, and F-score metric computed were 96.05%, 94.07%, and 95.06%, respectively. The model also has a least latency of 0.8 sec. Thus, it is demonstrated that chronic disease diagnosis can be significantly improved by heuristic-based attribute selection coupled with clustering followed by classification. It can be used to develop a decision support system to assist medical experts in the effective analysis of chronic diseases in a cost-effective manner.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.